Main Topic Area
All Topic Areas
1 - 10 of 111 more >>
Articles
1 - 5 of 17 more >>
- Thymoma and Thymic Carcinoma Treatment
Treatment may be one of the following: Surgery to remove the cancer. Radiation therapy in rare cases. Treatment may be one of the following: Surgery to remove the cancer followed by adjuvant radiation therapy. Radiation therapy alone, if the cancer cannot be removed by surgery. A clinical trial of chemotherapy. A clinical trial of chemotherapy followed by surgery. A clinical trial of chemotherapy combined with radiation therapy if the cancer cannot be removed by surgery. Treatment may be one of...
National Cancer Institute
- Genes and Disease: Lung carcinoma, small cell
In the US, lung cancer is the most common cause of cancer deaths among both men and women. In fact, North Americans have the highest rates of lung cancer in the world. In 1997, some 178,100 new cases were diagnosed, and roughly 160,400 deaths occurred from the disease. Sadly, the 5-year survival rate for persons with lung cancer is only 14%. Since the 1940s, the increase in lung cancer mortality by gender has followed historic patterns of smoking, with a 20-year time lag. About 90% of male lung...
National Center for Biotechnology Information
- Pancreatic Islet Transplantation
The pancreas, an organ about the size of a hand, is located behind the lower part of the stomach. It makes insulin and enzymes that help the body digest and use food. Spread all over the pancreas are clusters of cells called the islets of Langerhans. Islets are made up of two types of cells: alpha cells, which make glucagon, a hormone that raises the level of glucose (sugar) in the blood, and beta cells, which make insulin. Islet Functions Insulin is a hormone that helps the body use glucose...
National Institute of Diabetes and Digestive and Kidney Diseases
- Pancreatic Cancer Treatment
Recurrent pancreatic cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the pancreas or in other parts of the body. Treatment of recurrent pancreatic cancer may include the following: Chemotherapy. Palliative surgery or stent placement to bypass blocked areas in ducts or the small intestine. Palliative radiation therapy. Other palliative medical care to reduce symptoms, such as nerve blocks to relieve pain. Clinical trials of chemotherapy or...
National Cancer Institute
- Islet Cell Carcinoma (Pancreatic) Treatment
Treatment may be one of the following: Surgery to remove the cancer. Surgery to remove the stomach (gastrectomy). Surgery to cut the nerve that stimulates the pancreas. Chemotherapy. Hormone therapy. Hepatic arterial occlusion or embolization to kill cancer cells growing in the liver. Treatment may be one of the following: Surgery to remove the cancer. Chemotherapy. Hormone therapy. Drugs to relieve symptoms. Hepatic arterial occlusion or embolization to kill cancer cells growing in the liver....
National Cancer Institute
News
1 - 5 of 358 more >>
- Type 1 diabetes linked to pancreatic cancer risk
Reuters - Thu, 01 Mar 2007 05:24 EST
- Threshold Pharmaceuticals Announces That A Phase 3 Clinical Trial Of Glufosfamide For Treatment Of Pancreatic Cancer Did Not Meet Its Primary Endpoint
MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST
- First Evidence Of Stem Cells In Pancreatic Tumors
ScienceDaily - Mon, 12 Feb 2007 04:00 EST
- Serum Immunosuppressive Acidic Protein Doubling Time As A Prognostic Factor For Recurrent Renal Cell Carcinoma After Nephrectomy
MedicalNewsToday - Mon, 26 Feb 2007 08:00 EST
- Incidence Of Benign Pathologic Findings At Partial Nephrectomy For Solitary Renal Mass Presumed To Be Renal Cell Carcinoma On Preoperative Imaging
MedicalNewsToday - Mon, 05 Mar 2007 08:00 EST
Clinical Trials
1 - 5 of 1867 more >>
- Docetaxel in Combination with Iressa in Previously Treated Patients with Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00137761 - Active, not recruiting
Metastatic pancreatic carcinoma
- Safety and Efficacy of G17DT Immunogen in the Treatment of Advanced Pancreatic Carcinoma
ClinicalTrials.gov Identifier: NCT00044031 - Active, not recruiting
Pancreatic Cancer
- Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00226746 - Recruiting
Carcinoma, Pancreatic Ductal
- A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00480584 - Recruiting
Metastatic Pancreatic Carcinoma
- A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
ClinicalTrials.gov Identifier: NCT00411762 - Recruiting
Pancreatic Cancer

Not Signed In -

